ICU Quick Drug Guide

Description:

Offering essential, evidence-based practice guidelines specifically for the critical care setting, ICU Quick Drug Guide contains up-to-date information in a quick-access format. This portable handbook provides fast, accurate drug therapy information needed at the point of care, including expert advice throughout to help clinicians determine optimal pharmacological therapy.

• Offers a quick summary of current clinical guidelines to experienced clinicians while providing a simplified, focused guide to all entry level clinicians.
• Covers the wide variety of issues seen in the ICU, including sepsis and septic shock, venous thromboembolism, acute heart failure, anaphylaxis, arrhythmias, asthma and COPD, pain, infections, pancreatitis and liver failure, stroke, and many more.
• Begins each topic with a brief discussion of the disease state followed by drug tables that compare and contrast different treatment regimens, including pharmacokinetics, pharmacodynamics, drug interactions, contraindications, and hepatic/renal dosing.
• Contains clinical pearls organized by the top disease states seen in the critical/acute care setting.
• Provides practical and essential drug information from Dr. Jennifer Pai Lee, a clinical pharmacist with expertise in critical care and pharmacokinetics/pharmacodynamics.

Table of Contents:

1.    SECTION 1. CARDIOVASCULAR CRITICAL CARE

2.    1.  Acute coronary syndromes

3.    Clinical signs and symptoms of ACS (fig. 1.1)

4.    Causes of troponin elevations (box 1.1)

5.    Acute management of ACS

6.    References

7.    2.  Acutely decompensated heart failure (ADHF)

8.    Definitions

9.    Precipitating factors

10.  Pharmacologic management

11.  References

12.  3.  Adult advanced cardiovascular life support

13.  Asystole/pulseless electrical activity

14.  Ventricular fibrillation/pulseless ventricular tachycardia

15.  Bradycardia with pulse

16.  Tachycardia with pulse

17.  Post-cardiac arrest care

18.  Targeted temperature management (TTM) or therapeutic hypothermia (TH)

19.  References

20.  4.  Anticoagulation for atrial fibrillation or atrial flutter

21.  Anticoagulation to prevent thromboembolism in atrial fibrillation (AF) or atrial flutter

22.  References

23.  5.  Hypertensive crisis

24.  Definitions

25.  Management

26.  References

27.  SECTION 2. ENDOCRINE, GASTROINTESTINAL, AND HEPATIC DISORDERS

28.  6.  Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)

29.  Introduction

30.  Diagnosis criteria (table 6.1)

31.  Management (table 6.2)

32.  Insulin preparations (table 6.3)

33.  References

34.  7.  Other endocrine emergencies

35.  Thyroid storm

36.  Myxedema coma

37.  Adrenal crisis

38.  References

39.  8.  Gastroenterology

40.  GI fistulas

41.  Postoperative ileus (POI)

42.  Postoperative nausea and vomiting (PONV)

43.  Upper GI bleeding (UGIB)

44.  References

45.  9.  Severe acute pancreatitis and liver failure

46.  Severe acute pancreatitis

47.  Liver failure

48.  Hepatic encephalopathy

49.  References

50.  SECTION 3. INFECTIOUS DISEASES

51.  10.  Abdominal infections

52.  Complicated intra-abdominal infection

53.  Clostridium difficile infection (CDI)

54.  References

55.  11.  Other infections

56.  Hospital-acquired and ventilator-associated pneumonia

57.  Community-associated pneumonia

58.  Influenza

59.  Intravascular catheter-related infections

60.  Catheter-associated urinary tract infections (cautis)

61.  Skin and soft tissue infections (SSTIs)

62.  Antimicrobial prophylaxis in surgery

63.  Bacterial meningitis

64.  References

65.  12.  Sepsis and septic shock

66.  Definitions

67.  Management of sepsis and septic shock

68.  References

69.  SECTION 4. NEUROCRITICAL CARE

70.  13.  Acute ischemic stroke (AIS)

71.  Definitions

72.  Classification of stroke types (fig. 13.1)

73.  National institutes of health stroke scale (table 13.1)

74.  Management

75.  References

76.  14.  Other neurocritical care

77.  Myasthenia crisis

78.  Guillain-barre syndrome

79.  Antithrombotic-induced intracranial hemorrhage

80.  References

81.  15.  Status epilepticus

82.  References

83.  SECTION 5. PULMONARY DISORDERS

84.  16.  Asthma and chronic obstructive pulmonary disease (COPD) exacerbation

85.  Asthma exacerbation

86.  Chronic obstructive pulmonary disease (COPD) exacerbation

87.  References

88.  17.  Pulmonary arterial hypertension (group 1 pulmonary hypertension)

89.  References

90.  SECTION 6. MISCELLANEOUS

91.  18.  Acute alcohol and drug poisoning

92.  Introduction

93.  Management after patient stabilization

94.  References

95.  19.  Anaphylaxis

96.  Introduction

97.  Signs and symptoms (table 19.1)

98.  Triggers (table 19.2)

99.  Acute management (table 19.3)

100.               Prevention

101.               References

102.               20.  Drug-induced hyperthermia

103.               Malignant hyperthermia (MH)

104.               Neuroleptic malignant syndrome (NMS)

105.               Serotonin syndrome

106.               References

107.               21.  Fluids and electrolyte disorders

108.               General overview (tables 21.1, 21.2, and 21.3)

109.               Hypernatremia

110.               Hyponatremia

111.               Other electrolyte abnormalities and management (table 21.6)

112.               References

113.               22.  Pain, agitation, delirium, and neuromuscular blockade in the intensive care unit (ICU)

114.               Pain

115.               Agitation

116.               Delirium

117.               Neuromuscular blockade

118.               References

119.               23.  Rapid sequence induction

120.               Introduction

121.               Pharmacotherapy

122.               Vasopressors for blood pressure support

123.               References

124.               24.  Venous thromboembolism (VTE)

125.               Introduction

126.               Risk factors for VTE

127.               Prevalence of VTE

128.               Thromboprophylaxis

129.               Treatment of VTE with anticoagulants

130.               References

131.               Appendix

132.               References

133.               Index